Financial Ratios

DECIPHER LABS LTD.

NSE : NABSE : 524752ISIN CODE : INE643N01012Industry : Pharmaceuticals & DrugsHouse : MNC
BSE12.320.15 (+1.23 %)
PREV CLOSE ( ) 12.17
OPEN PRICE ( ) 12.40
BID PRICE (QTY) 12.11 (70)
OFFER PRICE (QTY) 12.32 (187)
VOLUME 4673
TODAY'S LOW / HIGH ( )11.53 12.40
52 WK LOW / HIGH ( ) 10.0124.6
NSE
This Company is not listed in NSE
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs)0.02-2.590.360.100.17
   CEPS(Rs)0.04-2.530.410.140.17
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)8.848.8211.4111.0510.96
   Tax Rate(%)7.170.81-0.704.18-0.30
Margin Ratios
   Core EBITDA Margin(%)0.56-45.4636.631.5911.09
   EBIT Margin(%)0.71-325.7936.2112.1211.77
   Pre Tax Margin(%)0.71-325.7936.2110.2911.77
   PAT Margin (%)0.66-323.1536.469.8611.80
   Cash Profit Margin (%)1.07-316.0641.5314.1112.05
Performance Ratios
   ROA(%)0.21-25.453.130.831.92
   ROE(%)0.26-25.633.180.872.48
   ROCE(%)0.28-25.843.141.052.40
   Asset Turnover(x)0.330.080.090.080.16
   Sales/Fixed Asset(x)14.552.412.704.7223.73
   Working Capital/Sales(x)25.578.230.390.390.56
Efficiency Ratios
   Fixed Capital/Sales(x)0.070.420.370.210.04
   Receivable days210.4577.24116.25110.08411.72
   Inventory Days0.000.0016.3267.8682.08
   Payable days429.9999.11989.62
Valuation Parameters
   PER(x)639.390.00148.39351.19113.32
   PCE(x)394.65-5.60130.28245.35111.01
   Price/Book(x)1.671.614.643.031.72
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)4.2217.6254.0634.7413.52
   EV/Core EBITDA(x)376.04-41.99130.96212.15112.51
   EV/EBIT(x)593.27-5.41149.29286.57114.86
   EV/CE(x)1.671.604.602.971.65
   M Cap / Sales4.2217.6954.1134.6213.37
Growth Ratio
   Net Sales Growth(%)336.00-18.051.27-31.44-79.01
   Core EBITDA Growth(%)111.65-183.33155.32-6.55-54.71
   EBIT Growth(%)100.95-837.33202.54-29.37-55.57
   PAT Growth(%)100.89-826.28274.64-42.74-55.43
   EPS Growth(%)100.89-826.28274.64-42.74-64.69
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.010.02
   Current Ratio(x)1.042.1532.3611.775.36
   Quick Ratio(x)1.042.1531.8111.584.81
   Interest Cover(x)6.61
   Total Debt/Mcap(x)0.000.000.000.000.01

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.